At HCRI, we recognize the profound role that biomarkers can play in therapeutic decisions. Biomarkers are measurable substances whose presence is indicative of disease, infection, or environmental exposure. In oncology, these can be used to detect cancer at an early stage, determine the prognosis, predict and monitor the response to treatment, and anticipate the likelihood of recurrence

As the clinical relevance of biomarkers continues to evolve and expand, our research teams are engaged in rigorous studies aimed at the identification and validation of novel cancer biomarkers. We strive to apply this knowledge to clinical practice, enhancing our ability to make accurate, individualized therapeutic decisions. By doing so, we can ensure that our patients receive the most appropriate and effective treatments at the right time